Terms: = Pancreatic cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
10 results:
1. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer.
Jia YH; Zheng WW; Ye ZH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2358-2367. PubMed ID: 32196587
[TBL] [Abstract] [Full Text] [Related]
3. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986-2009: a population-based study.
Jonsdottir SB; Juliusson G; Kristinsson JÖ; Hreinsson JP; Jonasson JG; Björnsson ES
Scand J Gastroenterol; 2018 Jan; 53(1):100-106. PubMed ID: 29058490
[TBL] [Abstract] [Full Text] [Related]
4. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract] [Full Text] [Related]
5. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract] [Full Text] [Related]
6. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract] [Full Text] [Related]
7. 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer.
Xi Y; Guo R; Hu J; Zhang M; Zhang X; Li B
Nucl Med Commun; 2014 Nov; 35(11):1112-8. PubMed ID: 25098308
[TBL] [Abstract] [Full Text] [Related]
8. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T; Güngör C; Thieltges S; Möller-Krull M; Penas EM; Wicklein D; Streichert T; Schumacher U; Kalinin V; Simon R; Otto B; Dierlamm J; Schwarzenbach H; Effenberger KE; Bockhorn M; Izbicki JR; Yekebas EF
BMC Cancer; 2010 Jun; 10():295. PubMed ID: 20553613
[TBL] [Abstract] [Full Text] [Related]
10. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract] [Full Text] [Related]